Detailed view for Rv3272

Basic information

TDR Targets ID: 9041
Mycobacterium tuberculosis, Conserved hypothetical protein

Source Database / ID:  Tuberculist 

pI: 7.4739 | Length (AA): 394 | MW (Da): 42459 | Paralog Number: 0

Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0

Druggability Group : DG1

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF02515   CoA-transferase family III

Gene Ontology

Mouse over links to read term descriptions.
GO:0003824   catalytic activity  
GO:0008152   metabolic process  

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 5 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
1 393 1xk7 (A) 4 384 20.00 0 1 1.17386 0.23
7 393 2vjq (A) 2 411 26.00 0 1 1.26903 -0.1
8 392 4ed9 (A) 4 376 32.00 0 1 1.33456 -0.06
8 393 3ubm (A) 9 417 28.00 0 1 1.2785 -0.02
9 383 2g04 (A) 6 350 34.00 0 1 1.10548 0.69

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

  • 5YIT:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 5YIY:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 5YX6:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date

Expression

Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile Dormant phase. hasan
Upregulation Percent Ranking Stage Dataset
Lower 0-20% percentile Dormant phase. murphy
Show/Hide expression data references
  • hasan Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis.
  • murphy Identification of gene targets against dormant phase Mycobacterium tuberculosis infections.

Orthologs

Ortholog group members (OG5_128463)

Species Accession Gene Product
Dictyostelium discoideum DDB_G0269880   CAIB/BAIF family protein
Drosophila melanogaster Dmel_CG10877   CG10877 gene product from transcript CG10877-RA
Escherichia coli b2374   formyl-CoA transferase, NAD(P)-binding
Escherichia coli b0038   crotonobetainyl CoA:carnitine CoA transferase
Escherichia coli b2371   acetyl-CoA:oxalate CoA-transferase
Homo sapiens ENSG00000175600   succinyl-CoA:glutarate-CoA transferase
Mus musculus 192136   succinyl-CoA glutarate-CoA transferase
Mycobacterium tuberculosis Rv3272   Conserved hypothetical protein
Mycobacterium ulcerans MUL_3896   acyl-CoA transferase/carnitine dehydratase
Mycobacterium ulcerans MUL_2621   acyl-CoA transferase
Mycobacterium ulcerans MUL_3873   dehydratase
Mycobacterium ulcerans MUL_1046   acyl-CoA transferase
Mycobacterium ulcerans MUL_2446   hypothetical protein
Mycobacterium ulcerans MUL_0328   acyl-CoA transferase
Mycobacterium ulcerans MUL_0364   acyl-CoA transferase
Schmidtea mediterranea mk4.002124.07  
Schmidtea mediterranea mk4.005334.00   SuccinateALQ-hydroxymethylglutarate CoA-transferase
Schmidtea mediterranea mk4.002124.09   SuccinateALQ-hydroxymethylglutarate CoA-transferase
Schmidtea mediterranea mk4.004611.01  

Essentiality

Rv3272 has direct evidence of essentiality
Gene/Ortholog Organism Phenotype Source Study
mtu3331 this record Mycobacterium tuberculosis non-essential nmpdr
b0038 Escherichia coli non-essential goodall
b2371 Escherichia coli non-essential goodall
b2374 Escherichia coli non-essential goodall
Show/Hide essentiality data references
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.


Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets

Obtained from network model
No druggable targets predicted through repurposing network model

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier Rv3272 (Mycobacterium tuberculosis), Conserved hypothetical protein
Title for this comment
Comment